Vasorin is a potential serum biomarker and drug target of hepatocarcinoma screened by subtractive-EMSA-SELEX to clinic patient serum

We report a new biomarker of hepatocarcinoma, vasorin (VASN), screened by a subtractive EMSA-SELEX strategy from AFP negative serum of hepatocellular carcinoma (HCC) patients with extrahepatic metastases. VASN was verified to be highly expressed in sera of 100 cases of HCC patients compared with 97...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Li, Shaohua, Li, Hui, Yang, Xiqin, Wang, Wei, Huang, Aixue, Li, Jie, Qin, Xingliang, Li, Fei, Lu, Guanyi, Ding, Hongmei, Su, Xueting, Hou, Lvbin, Xia, Wei, Shi, Ming, Zhang, Hongwen, Zhao, Qiang, Dong, Jie, Ge, Xingfeng, Sun, Leqiao, Bai, Chenjun, Wang, Chaonan, Shen, Xuelian, Fang, Tao, Wang, Fusheng, Zhang, Heqiu, Shao, Ningsheng
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2015
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4496339/
https://ncbi.nlm.nih.gov/pubmed/25826090
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados